Install
Vaccines & Immunology
mRNA platforms, boosters, monoclonals, and immune‑system science.
- 18 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Vaccines & Immunology
Causal multi-modal AI predicts who benefits from chemotherapy — and who will not
5+ hour, 50+ min ago (510+ words) Authors: Dhruva Biswas and Krzysztof J. Geras AI-enabled perception of how treatment choice shapes patient trajectories. Causal multi-modal AI turns routine pathology and clinical data into personalized estimates of chemosensitivity, separating risk of recurrence from treatment benefit to help direct chemotherapy…...
Ataraxis AI Publishes Landmark Studies Showing Causal AI Predicts Chemotherapy Benefit in Multiple Solid Tumors
14+ hour, 10+ min ago (324+ words) NEW YORK, September 14, 2026--(BUSINESS WIRE)--Ataraxis AI, a company building clinical AI tools to personalize cancer care, today announced scientific breakthroughs and validation results of Ataraxis's AI models. Ataraxis developed breakthrough causal AI methods that learn from large-scale, longitudinal data…...
Cellectis Exits Two CAR-T Programs, Advances Gene Editing
21+ hour, 30+ min ago (140+ words) Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise → © OpenServe Holdings LLC Where do you stand? What each side asserts, disputes — or leaves out entirely. Whose framing of this story rings truest to…...
KAIST cracks the code of RNA delivery in brain cells, opening new path for neurological treatment
22+ hour, 36+ min ago (490+ words) - Chemical tag m6A acts as a 'delivery label,' guiding RNA to the far ends of neurons - Study reveals new transport function of YTHDF2, previously known only as an RNA-degrading protein - Findings expected to shed light on RNA delivery errors behind neurodevelopmental and…...
KAIST Team Reveals Neuron RNA Delivery Mechanism
20+ hour, 4+ min ago (769+ words) < (From left) Bonsang Koo, Huiseon Hwang, and Minyeong Park, students in the Department of Biological Sciences, and Professor Ki-Jun Yoon > Much like a courier reading an address on a package, neurons must deliver RNA to the precise locations where it is needed. A KAIST research team has discovered how a small chemical modification on RNA acts as a "delivery tag,…...
New partnership to strengthen CAR-T cell therapy manufacturing capabilities in Japan
1+ day, 5+ hour ago (258+ words) BioSpectrum Asia New partnership to strengthen CAR-T cell therapy manufacturing capabilities in Japan September 13, 2026 | Sunday | News Teijin, Teijin Regenet and Shinshu University Hospital to contribute to the advancement of cell and gene therapies in Japan Teijin Limited, Teijin Regenet Co.,…...
Trace mineral injection improves calves' vaccine response at weaning
1+ day, 10+ hour ago (296+ words) An injectable trace mineral given at weaning could improve calves’ response to respiratory disease vaccines, according to new research from Mississippi State University and Louisiana State University, although its effect on weight gain is less clear. The study followed 34 beef…...
India emerges as global vaccine powerhouse, can lead next-generation epidemic preparedness: Dr Jitendra Singh
1+ day, 11+ hour ago (254+ words) New Delhi, Sep 13 (IANS) India has emerged as the world’s largest vaccine producer and a major global supplier by volume, with its diverse disease landscape and expanding scientific capabilities offering a unique platform for vaccine research, epidemic preparedness and the…...
Receptor Occupancy Fails to Predict Immune Activation in Pembrolizumab
1+ day, 15+ hour ago (55+ words) Pembrolizumab, one of the most widely prescribed cancer immunotherapies in the world, has long been dosed on the assumption that saturating the PD-1 receptor on T cells is the key to unlocking the immune system against tumours. A new translational…...
Engineered T Cell Receptors With Built-In ICOS Deliver Long-Lasting
1+ day, 15+ hour ago (120+ words) Adoptive T cell therapy has delivered striking remissions in some blood cancers, but its promise in solid tumors has been repeatedly undermined by a stubborn problem: the therapeutic cells do not last. Engineered T cells that flood a tumor and…...